CN105223358B - 一种子宫内膜癌特异性检测的试剂盒 - Google Patents
一种子宫内膜癌特异性检测的试剂盒 Download PDFInfo
- Publication number
- CN105223358B CN105223358B CN201510807002.6A CN201510807002A CN105223358B CN 105223358 B CN105223358 B CN 105223358B CN 201510807002 A CN201510807002 A CN 201510807002A CN 105223358 B CN105223358 B CN 105223358B
- Authority
- CN
- China
- Prior art keywords
- cypa
- aptamer
- carcinoma
- endometrium
- test kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010014759 Endometrial neoplasm Diseases 0.000 title claims abstract description 18
- 201000003914 endometrial carcinoma Diseases 0.000 title claims abstract description 14
- 238000012360 testing method Methods 0.000 title claims abstract description 11
- 238000011895 specific detection Methods 0.000 title abstract description 4
- 108091023037 Aptamer Proteins 0.000 claims abstract description 45
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 241001044073 Cypa Species 0.000 claims 1
- 108010072220 Cyclophilin A Proteins 0.000 abstract description 3
- 102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 102100040283 Peptidyl-prolyl cis-trans isomerase B Human genes 0.000 abstract 1
- 108010044156 peptidyl-prolyl cis-trans isomerase b Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 24
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 102000053602 DNA Human genes 0.000 description 8
- 241001597008 Nomeidae Species 0.000 description 7
- 239000012528 membrane Substances 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000005002 female reproductive tract Anatomy 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 101001067833 Homo sapiens Peptidyl-prolyl cis-trans isomerase A Proteins 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 108090000175 Cis-trans-isomerases Proteins 0.000 description 1
- 102000003813 Cis-trans-isomerases Human genes 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 101900045614 Escherichia coli Outer membrane protein A Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 108091008103 RNA aptamers Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000006044 T cell activation Effects 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KNYAHOBESA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] dihydroxyphosphoryl hydrogen phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)O[32P](O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KNYAHOBESA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- -1 pg120 albumen Proteins 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/99—Isomerases (5.)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
名称 | 解离常数Kd(单位nM) |
CYPA-1 | 11.3 |
CYPA -2 | 12.5 |
CYPA -3 | 13.0 |
CYPA -4 | 12.8 |
CYPA -5 | 12.7 |
CYPA -6 | 11.9 |
CYPA -7 | 11.4 |
CYPA -8 | 12.4 |
CYPA -9 | 12.7 |
CYPA -10 | 12.0 |
CYPA -11 | 13.1 |
CYPA -12 | 13.0 |
CYPA -13 | 12.6 |
CYPA -14 | 12.8 |
PBS空白对照 | 无结合能力 |
Claims (1)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510807002.6A CN105223358B (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610370068.8A CN105842446A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361917.3A CN105842444A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361860.7A CN105866411A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361858.XA CN105954516A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610369946.4A CN105866412A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361916.9A CN105807069A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361857.5A CN105807068A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361859.4A CN105807054A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610370066.9A CN105842445A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510807002.6A CN105223358B (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
Related Child Applications (13)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610370003.3A Division CN105823879A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361916.9A Division CN105807069A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610369830.0A Division CN105785007A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610370068.8A Division CN105842446A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361857.5A Division CN105807068A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361917.3A Division CN105842444A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361858.XA Division CN105954516A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361860.7A Division CN105866411A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610370066.9A Division CN105842445A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610370002.9A Division CN105823895A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610369948.3A Division CN105823894A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361859.4A Division CN105807054A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610369946.4A Division CN105866412A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105223358A CN105223358A (zh) | 2016-01-06 |
CN105223358B true CN105223358B (zh) | 2016-09-14 |
Family
ID=54992426
Family Applications (10)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610361860.7A Pending CN105866411A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610369946.4A Pending CN105866412A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610370066.9A Pending CN105842445A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361859.4A Pending CN105807054A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610370068.8A Pending CN105842446A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361916.9A Pending CN105807069A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361857.5A Pending CN105807068A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361858.XA Pending CN105954516A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361917.3A Pending CN105842444A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201510807002.6A Active CN105223358B (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
Family Applications Before (9)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610361860.7A Pending CN105866411A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610369946.4A Pending CN105866412A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610370066.9A Pending CN105842445A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361859.4A Pending CN105807054A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610370068.8A Pending CN105842446A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361916.9A Pending CN105807069A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361857.5A Pending CN105807068A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361858.XA Pending CN105954516A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
CN201610361917.3A Pending CN105842444A (zh) | 2015-11-22 | 2015-11-22 | 一种子宫内膜癌特异性检测的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (10) | CN105866411A (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105886659A (zh) * | 2016-06-29 | 2016-08-24 | 北京泱深生物信息技术有限公司 | Dstn基因及其表达产物作为子宫内膜癌的诊治靶标 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451609B1 (en) * | 1996-05-30 | 2002-09-17 | The Cleveland Clinic Foundation | Method of detecting gynecological carcinomas |
US6591144B2 (en) * | 2001-10-23 | 2003-07-08 | The Administrators Of The Tulane Educational Fund | Steerable catheter and method for locating coronary sinus |
CN101261279B (zh) * | 2008-04-11 | 2012-07-04 | 四川大学 | 子宫内膜癌诊断试剂、试剂盒及防治药物 |
GB201001444D0 (en) * | 2010-01-29 | 2010-03-17 | Cambridge Entpr Ltd | Biomarkers |
JP6509745B2 (ja) * | 2013-01-25 | 2019-05-08 | エックスセル・バイオサイエンシズ・インコーポレイテッド | 標的細胞の選択的富化のための方法、組成物、キット、及びシステム |
CN104109667B (zh) * | 2014-06-24 | 2017-04-05 | 叶尚勉 | 一种核酸片段及其用途 |
CN104830867A (zh) * | 2015-06-07 | 2015-08-12 | 杨洋 | 一种能够特异性结合癌细胞中的dkk1蛋白的适配子 |
-
2015
- 2015-11-22 CN CN201610361860.7A patent/CN105866411A/zh active Pending
- 2015-11-22 CN CN201610369946.4A patent/CN105866412A/zh active Pending
- 2015-11-22 CN CN201610370066.9A patent/CN105842445A/zh active Pending
- 2015-11-22 CN CN201610361859.4A patent/CN105807054A/zh active Pending
- 2015-11-22 CN CN201610370068.8A patent/CN105842446A/zh active Pending
- 2015-11-22 CN CN201610361916.9A patent/CN105807069A/zh active Pending
- 2015-11-22 CN CN201610361857.5A patent/CN105807068A/zh active Pending
- 2015-11-22 CN CN201610361858.XA patent/CN105954516A/zh active Pending
- 2015-11-22 CN CN201610361917.3A patent/CN105842444A/zh active Pending
- 2015-11-22 CN CN201510807002.6A patent/CN105223358B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN105842444A (zh) | 2016-08-10 |
CN105223358A (zh) | 2016-01-06 |
CN105807068A (zh) | 2016-07-27 |
CN105866411A (zh) | 2016-08-17 |
CN105842445A (zh) | 2016-08-10 |
CN105954516A (zh) | 2016-09-21 |
CN105807054A (zh) | 2016-07-27 |
CN105807069A (zh) | 2016-07-27 |
CN105842446A (zh) | 2016-08-10 |
CN105866412A (zh) | 2016-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105223358B (zh) | 一种子宫内膜癌特异性检测的试剂盒 | |
CN105203763B (zh) | 一种口腔癌特异性检测的试剂盒 | |
CN106093434A (zh) | 一种用于肝癌检测的试剂盒 | |
CN105823894A (zh) | 一种子宫内膜癌特异性检测的试剂盒 | |
CN105823895A (zh) | 一种子宫内膜癌特异性检测的试剂盒 | |
CN105823879A (zh) | 一种子宫内膜癌特异性检测的试剂盒 | |
CN105785007A (zh) | 一种子宫内膜癌特异性检测的试剂盒 | |
CN105353126B (zh) | 一种唇癌特异性检测的试剂盒 | |
CN106018836A (zh) | 一种用于检测眼病的试剂盒及其检测方法 | |
CN105177013A (zh) | 一种用于检测脑血管疾病的试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Lv Jing Inventor after: Deng Tao Inventor after: Zhang Zhiwei Inventor after: Zhu Xiuhuang Inventor before: Li Jing |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160805 Address after: 100176 Beijing branch of Beijing economic and Technological Development Zone Street 88 Hospital No. 9 Building 2 unit Applicant after: Beijing CapitalBio MedLab Co., Ltd. Address before: Puyang City, Henan province 457000 Changqing Road and road intersection Su drilling two companies Applicant before: Li Jing |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180330 Address after: 410005 Ba street, Ba street, Yuelu District, Changsha, Hunan Province, No. 152, Changsha Yuelu science and Technology Industrial Park, Zhi Xin building, four building Patentee after: Changsha Boao Medical Laboratory Limited Address before: 100176 Beijing branch of Beijing economic and Technological Development Zone Street 88 Hospital No. 9 Building 2 unit Patentee before: Beijing CapitalBio MedLab Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 410005 Ba street, Ba street, Yuelu District, Changsha, Hunan Province, No. 152, Changsha Yuelu science and Technology Industrial Park, Zhi Xin building, four building Patentee after: Changsha Bo'ao Medical Technology Co., Ltd Address before: 410005 Ba street, Ba street, Yuelu District, Changsha, Hunan Province, No. 152, Changsha Yuelu science and Technology Industrial Park, Zhi Xin building, four building Patentee before: Changsha boo Medical Laboratory Limited |